💊 OneSource Specialty Pharma Q3: Losses Widen, Revenue Declines Sharply

OneSource Specialty Pharma reported a weak Q3 performance, posting a net loss of ₹88.7 crore, compared with a ₹68.8 crore loss in the same quarter last year. Revenue declined sharply to ₹290 crore from ₹392 crore, while EBITDA fell to ₹17.3 crore from ₹143 crore. EBITDA margins contracted significantly to 5.96% from 36.47% YoY. It is important to note that last year’s results included a one-time exceptional gain of ₹101 crore, which had boosted profitability. #OneSource #PharmaStocks #Q3Results #EarningsUpdate #StockYardResearch